These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7213525)

  • 1. A new technique for recording compliance of human hand veins.
    Aellig WH
    Br J Clin Pharmacol; 1981 Mar; 11(3):237-43. PubMed ID: 7213525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for studying drug effects on superficial human veins.
    Aellig WH
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):321-4. PubMed ID: 3840550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial hand and foot veins show no difference in sensitivity to constrictor agents.
    Aellig WH
    Clin Pharmacol Ther; 1990 Jul; 48(1):96-101. PubMed ID: 2369808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effects of vasoactive substances on superficial human veins in vivo.
    Aellig WH
    Int Angiol; 1985; 4(2):235-42. PubMed ID: 3913713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity.
    Alradi AO; Carruthers SG
    Clin Pharmacol Ther; 1985 Nov; 38(5):495-502. PubMed ID: 2996818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The recording of venous compliance in the conscious dog: a method for the assessment of venoconstrictor agents.
    Müller-Schweinitzer E
    J Pharmacol Methods; 1984 Aug; 12(1):53-8. PubMed ID: 6536814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of dihydroergotamine with etilefrine in human leg veins in vitro and in situ.
    Barthel W; Glusa E; Koth W
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):63-9. PubMed ID: 2881898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.
    Aellig WH
    Eur J Clin Pharmacol; 1984; 26(2):239-42. PubMed ID: 6547094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology, physiology and pathophysiology of superficial veins--1.
    Aellig WH
    Br J Clin Pharmacol; 1994 Sep; 38(3):181-96. PubMed ID: 7826819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different congestion pressures on the diameter of the dorsal hand vein and on its apparent sensitivity to noradrenaline.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):324-7. PubMed ID: 8692288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
    Müller-Schweinitzer E; Rosenthaler J
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):686-93. PubMed ID: 2442535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative and noncumulative dose-response curves to noradrenaline on the dorsal hand vein.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    J Pharmacol Toxicol Methods; 1996 Oct; 36(2):77-80. PubMed ID: 8912225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of systemically given placebo, trapidil and isosorbide dinitrate on norepinephrine-evoked hand vein constriction in healthy subjects.
    Sziegoleit W; Dannenberg K; Konschak A; Lautenschläger C; Presek P
    Arzneimittelforschung; 2007; 57(2):81-6. PubMed ID: 17396617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man.
    Aellig WH
    Eur J Clin Pharmacol; 1983; 25(6):759-62. PubMed ID: 6662174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of blockade at alpha-adrenoceptors by thymoxamine and phentolamine in peripheral arteries and veins of man.
    Collier JG; Nachev C; Robinson BF
    Br J Pharmacol; 1972 Feb; 44(2):294-300. PubMed ID: 4148917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diameter, pressure and compliance relationships in dorsal hand veins.
    Shykoff BE; Hawari FI; Izzo JL
    Vasc Med; 2001; 6(2):97-102. PubMed ID: 11530971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo studies after oral treatment of the beagle with dihydroergotamine.
    Müller-Schweinitzer E; Rosenthaler J
    Eur J Pharmacol; 1983 Apr; 89(1-2):1-8. PubMed ID: 6861880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venoconstrictor effect of dihydroergotamine in superficial hand veins.
    Aellig WH
    Eur J Clin Pharmacol; 1974; 7(2):137-9. PubMed ID: 4855381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.